Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis |
The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measured as of September 30, 2022 |
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
|
(In thousands) |
Assets |
|
|
|
|
|
|
|
Money market funds (i) |
$ |
39,215 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
39,215 |
|
U.S. Treasury securities (ii) |
35,131 |
|
|
— |
|
|
— |
|
|
35,131 |
|
Corporate bonds (ii) |
— |
|
|
37,347 |
|
|
— |
|
|
37,347 |
|
Total financial assets |
$ |
74,346 |
|
|
$ |
37,347 |
|
|
$ |
— |
|
|
$ |
111,693 |
|
Liabilities |
|
|
|
|
|
|
|
Common stock warrant liabilities (Public) (iii) |
$ |
6,986 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
6,986 |
|
Common stock warrant liabilities (Private Placement) (iii) |
— |
|
|
— |
|
|
3,605 |
|
|
3,605 |
|
Common stock warrant liabilities (2022 Private Warrant) (iii) |
|
|
|
|
245 |
|
|
245 |
|
Contingent earnout liabilities |
— |
|
|
— |
|
|
53,377 |
|
|
53,377 |
|
Total financial liabilities |
$ |
6,986 |
|
|
$ |
— |
|
|
$ |
57,227 |
|
|
$ |
64,213 |
|
|
|
|
|
|
|
|
|
|
Fair Value Measured as of December 31, 2021 |
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
|
(In thousands) |
Assets |
|
|
|
|
|
|
|
Money market funds (i) |
$ |
207,471 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
207,471 |
|
U.S. Treasury securities (ii) |
8,141 |
|
|
— |
|
|
— |
|
|
8,141 |
|
Corporate bonds (ii) |
— |
|
|
7,342 |
|
|
— |
|
|
7,342 |
|
Total financial assets |
$ |
215,612 |
|
|
$ |
7,342 |
|
|
$ |
— |
|
|
$ |
222,954 |
|
Liabilities |
|
|
|
|
|
|
|
Common stock warrant liabilities (Public) (iii) |
$ |
14,318 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
14,318 |
|
Common stock warrant liabilities (Private Placement) (iii) |
— |
|
|
— |
|
|
7,387 |
|
|
7,387 |
|
Contingent earnout liabilities |
— |
|
|
— |
|
|
111,487 |
|
|
111,487 |
|
Total financial liabilities |
$ |
14,318 |
|
|
$ |
— |
|
|
$ |
118,874 |
|
|
$ |
133,192 |
|
(i) Included in cash and cash equivalents on the condensed consolidated balance sheets.
(ii) Included in short-term investments on the condensed consolidated balance sheets.
(iii) Included in warrant liabilities on the condensed consolidated balance sheets.
|
Summary of Changes in Fair Value of Level 3 Financial Instruments |
The following table presents a rollforward of the Level 3 assets and liabilities measured at fair value on a recurring basis:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable convertible preferred stock warrant liabilities |
|
Private placement warrant liabilities |
|
2022 Private Warrant |
|
Contingent earnout liabilities |
|
(In thousands) |
Three Months Ended September 30, 2022 |
|
Fair value as of June 30, 2022 |
$ |
— |
|
|
$ |
1,380 |
|
|
$ |
— |
|
|
$ |
12,492 |
|
Issuance of warrant |
— |
|
|
— |
|
|
170 |
|
|
— |
|
Change in fair value |
— |
|
|
2,225 |
|
|
75 |
|
|
40,885 |
|
Fair value as of September 30, 2022 |
$ |
— |
|
|
$ |
3,605 |
|
|
$ |
245 |
|
|
$ |
53,377 |
|
Nine months ended September 30, 2022 |
|
|
|
|
|
|
|
Fair value as of January 1, 2022 |
$ |
— |
|
|
$ |
7,387 |
|
|
$ |
— |
|
|
$ |
111,487 |
|
Issuance of warrant |
— |
|
|
— |
|
|
170 |
|
— |
|
Change in fair value |
— |
|
|
(3,782) |
|
|
75 |
|
|
(58,110) |
|
Fair value as of September 30, 2022 |
$ |
— |
|
|
$ |
3,605 |
|
|
$ |
245 |
|
|
$ |
53,377 |
|
Three Months Ended September 30, 2021 |
|
Fair value as of June 30, 2021 |
$ |
1,922 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Private placement warrant liabilities acquired as part of the reverse recapitalization |
— |
|
|
7,165 |
|
|
— |
|
|
— |
|
Contingent earnout liabilities recognized upon the closing of the reverse recapitalization |
— |
|
|
— |
|
|
— |
|
|
120,763 |
|
Exercise of warrants |
(899) |
|
|
— |
|
|
— |
|
|
— |
|
Change in fair value |
(1,023) |
|
|
(312) |
|
|
— |
|
|
(2,014) |
|
Fair value as of September 30, 2021 |
$ |
— |
|
|
$ |
6,853 |
|
|
$ |
— |
|
|
$ |
118,749 |
|
Nine months ended September 30, 2021 |
|
|
|
|
|
|
|
Fair value as of January 1, 2021 |
$ |
181 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Private placement warrant liabilities acquired as part of the reverse recapitalization |
— |
|
|
7,165 |
|
|
— |
|
|
— |
|
Contingent earnout liabilities recognized upon the closing of the reverse recapitalization |
— |
|
|
— |
|
|
— |
|
|
120,763 |
|
Exercise of warrants |
(899) |
|
|
— |
|
|
— |
|
|
— |
|
Change in fair value |
718 |
|
|
(312) |
|
|
— |
|
|
(2,014) |
|
Fair value as of September 30, 2021 |
$ |
— |
|
|
$ |
6,853 |
|
|
$ |
— |
|
|
$ |
118,749 |
|
|